68727-745 : Vyxeos Intravenous Injection, Powder, Lyophilized, for Suspension
NDC: | 68727-745 |
Labeler: | Jazz Pharmaceuticals, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Vyxeos |
Dosage Form: | Intravenous Injection, Powder, Lyophilized, for Suspension |
Application #: | NDA209401 |
Rev. Date: |
NDC Package Codes:
- 68727-745-01: 20 ML IN 1 VIAL (68727‑745‑01)
- 68727-745-02: 40 ML IN 1 CARTON (68727‑745‑02)
- 68727-745-05: 100 ML IN 1 CARTON (68727‑745‑05)
Active Ingredients:
- Cytarabine
- Daunorubicin
Dosage Strength:
- 100 mg/20mL
- 44 mg/20mL
Pharmaceutical Classes:
- Nucleic Acid Synthesis Inhibitors [MoA]
- Nucleoside Metabolic Inhibitor [EPC]
- Anthracycline Topoisomerase Inhibitor [EPC]
- Anthracyclines [CS]
- Topoisomerase Inhibitors [MoA]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 68727-712Next: 68727-800 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.